±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 297  |  »Ø¸´: 1

ÌÆÙ»

гæ (³õÈëÎÄ̳)

[ÇóÖú] ΢Æ×ÇóÖú ÒÑÓÐ1È˲ÎÓë

16.0,16.1,24.2,29.6,33.2,49.1,49.3,50.3,56.7,60.1,112.4,114.9,114.9,116.6,123.9,125.6,129.0,129.3,129.9,129.9,154.3,155.9,168.7,171.0,171.3,173.1,173.5.

[ Last edited by ׿Խ_ÏÈ·æ on 2015-6-2 at 13:16 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

seuseasoar

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
1 .     asperpeptide A
C27H31N5O7     ÏàËÆ¶È:81.4%
Journal of Natural Products          2014          77          1601-1606
Lumazine Peptides Penilumamides B¨CD and the Cyclic Pentapeptide Asperpeptide A from a Gorgonian-Derived Aspergillus sp. Fungus
Min Chen, Chang-Lun Shao, Xiu-Mei Fu, Chui-Jian Kong, Zhi-Gang She, and Chang-Yun Wang
Structure      13C NMR    Structure & 13C NMR     Ì¼Æ×Ä£Äâͼ
2 .     compound
    ÏàËÆ¶È:59.2%
Journal of Medicinal Chemistry          2014          57          7367−7381
Design, Synthesis, and Biological Evaluation of (3R)-1,2,3,4-Tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) Analogues: In Vitro Pharmacology and ADME Profil
Chad M. Kormos, Moses G. Gichinga, Rangan Maitra, Scott P. Runyon, James B. Thomas, Lawrence E. Brieaddy, S. Wayne Mascarella, Hern¨¢n A. Navarro, and F. Ivy Carroll
Structure      13C NMR    Structure & 13C NMR     Ì¼Æ×Ä£Äâͼ
3 .     Cbz-D-Ala-Abu-N,O-dimethyl-Tyr-Ala-OMe
C30H41N4O8     ÏàËÆ¶È:55.5%
Tetrahedron          2008          64          4117-4125
Structures of cytotoxic bicyclic hexapeptides, RA-XIX, -XX, -XXI, and -XXII, from Rubia cordifolia L.
Ji-Ean Lee, Yukio Hitotsuyanagi, Koichi Takeya
Structure      13C NMR    Structure & 13C NMR     Ì¼Æ×Ä£Äâͼ
4 .     argifin
C29H41N9O10     ÏàËÆ¶È:55.5%
The Journal of Antibiotics          2000          53          609-614
Argifin, a New Chitinase Inhibitor, Produced by Gliodadium sp. FTD-0668 II. Isolation, Physico-chemical Properties, and Structure Elucidation
NORIKO ARAI,KAZURO SHIOMI,YUZURU IWAI and SATOSHI OMURA
Structure      13C NMR    Structure & 13C NMR     Ì¼Æ×Ä£Äâͼ
5 .     (3R)-N-[(1S)-1-{[(3R,4R)-4-(3-bromophenyl)-3,4-dimethylpiperidin-1-yl]methyl}-2-methylpropyl]-7-hydroxy-1,2,3,4-tetra-hydroisoquinoline-3-carboxamide dihydrochloride
C28H40BrCl2N3O2     ÏàËÆ¶È:55.5%
Journal of Medicinal Chemistry          2014          57          7367−7381
Design, Synthesis, and Biological Evaluation of (3R)-1,2,3,4-Tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) Analogues: In Vitro Pharmacology and ADME Profil
Chad M. Kormos, Moses G. Gichinga, Rangan Maitra, Scott P. Runyon, James B. Thomas, Lawrence E. Brieaddy, S. Wayne Mascarella, Hern¨¢n A. Navarro, and F. Ivy Carroll
Structure      13C NMR    Structure & 13C NMR     Ì¼Æ×Ä£Äâͼ
6 .     argifin
C29H41N9O10     ÏàËÆ¶È:51.8%
Tetrahedron Letters          2000          41          2141-2143
Structure of argifin, a new chitinase inhibitor produced by Gliocladium sp.
Kazuro Shiomi, Noriko Arai, Yuzuru Iwai, Andreas Turberg, Heinz K?lbl, Satoshi mura
Structure      13C NMR    Structure & 13C NMR     Ì¼Æ×Ä£Äâͼ
7 .     Argifin
C29H42N9O10     ÏàËÆ¶È:51.8%
Bioorganic & Medicinal Chemistry Letters          2005          15          4717-4721
An efficient synthesis of argifin: A natural product chitinase inhibitor with chemotherapeutic potential
Mark J. Dixon, Ole A. Andersen, Daan M.F. van Aalten, Ian M. Eggleston
Structure      13C NMR    Structure & 13C NMR     Ì¼Æ×Ä£Äâͼ
8 .     Boc-Ile-Aib-Val-m-ABA-Ome
C28H44N4O7     ÏàËÆ¶È:51.8%
Helvetica Chimica Acta          2010          93          1025-1037
Amyloid-Like Fibrillogenesis through Supramolecular Helix-Mediated Self-Assembly of Tetrapeptides Containing Non-Coded -Aminoisobutyric Acid (Aib) and 3-Aminobenzoic Acid (m-ABA)
Arpita Dutta, Michael G. B. Drew and Animesh Pramanik
Structure      13C NMR    Structure & 13C NMR     Ì¼Æ×Ä£Äâͼ
ÄáºÕ
2Â¥2015-06-01 18:22:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÌÆÙ» µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +12 Ò»ÑùYWY 2026-04-05 13/650 2026-04-06 15:38 by lin-da
[¿¼ÑÐ] Ò»Ö¾Ô¸°²»Õij211 0703»¯Ñ§×Ü·Ö339Çóµ÷¼Á +7 Íí·ç²»Íí 2026-04-04 7/350 2026-04-06 14:06 by houyaoxu
[¿¼ÑÐ] ±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á +8 Á«²Ë¾ÍÊÇź°É 2026-04-03 9/450 2026-04-05 19:12 by À¶ÔÆË¼Óê
[¿¼ÑÐ] µ÷¼Á +5 ºÃºÃ¶ÁÊé¡£ 2026-04-01 5/250 2026-04-05 17:54 by liucky
[¿¼ÑÐ] µ÷¼ÁÇóÖú +10 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 13/650 2026-04-05 09:41 by sam3303
[¿¼ÑÐ] 291Çóµ÷¼Á +4 ÃÔÃÉľľ 2026-04-01 5/250 2026-04-04 15:59 by sihailian3
[¿¼ÑÐ] 348·Ö»·¾³¹¤³Ì¡¤µ÷¼Á +10 ÎâÑå׿24k 2026-04-03 11/550 2026-04-04 14:19 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358 +6 cs0106 2026-04-03 6/300 2026-04-04 11:20 by w_xuqing
[¿¼ÑÐ] ×Ü·Ö328ÉúÎïÓëÒ½Ò©¿¼ÊýѧÇóµ÷¼Á +7 aaadim 2026-04-02 9/450 2026-04-03 22:53 by syh9288
[¿¼ÑÐ] 357Çóµ÷¼Á +13 1050389037 2026-04-03 13/650 2026-04-03 22:27 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ¿¼Ñе÷¼Á +5 СsunÒªºÃÔË 2026-04-03 5/250 2026-04-03 21:43 by à£à£à£0119
[¿¼ÑÐ] 336Çóµ÷¼Á +8 kiyy 2026-04-01 8/400 2026-04-03 19:41 by lijunpoly
[¿¼ÑÐ] ÊýÒ»Ó¢Ò»285Çóµ÷¼Á +7 AZMK 2026-04-03 9/450 2026-04-03 13:03 by ms629
[¿¼ÑÐ] 318Çóµ÷¼Á£¬¼ÆËã²ÄÁÏ·½Ïò +10 Îüß÷Óк¦óÏÃü 2026-04-01 11/550 2026-04-02 16:29 by oooqiao
[¿¼ÑÐ] ¡¾Çóµ÷¼Á¡¿ÐÂÄÜÔ´²ÄÁϱ¾¿Æ£¬Ò»Ö¾Ô¸211£¬³õÊÔ321 +6 Çóµ÷¼ÁѧУ£¬ 2026-04-02 6/300 2026-04-02 09:41 by Çç¿Õ210210
[¿¼ÑÐ] 085410 Ò»Ö¾Ô¸211 22408·ÖÊý359Çóµ÷¼Á +3 123456789qw 2026-03-31 4/200 2026-04-02 00:06 by ÒåÎÄwang
[¿¼ÑÐ] 303·Ö 0807ѧ˶Çóµ÷¼Á +3 TYC3632 2026-04-01 3/150 2026-04-01 19:24 by lwk2004
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»²ÄÁϹ¤³Ì×Ü·Ö358 +5 cs0106 2026-04-01 7/350 2026-04-01 11:45 by wangjy2002
[¿¼ÑÐ] 301Çóµ÷¼Á +8 axibli 2026-04-01 8/400 2026-04-01 09:51 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 0710ÉúÎïѧÇóµ÷¼Á£¡ +6 ÐðÊöÎÄ 2026-03-31 6/300 2026-04-01 09:39 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û